Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Pyzchiva“
Suchtreffer
Begriffe & Kennungen
Pyzchiva · 4.8 · Infections In the placebo-controlled studies of patients with psoriasis, psoriatic arthritis, Crohn’s disease
Eintrag öffnenPyzchiva · 4.8 · Infections and infestations Common: Upper respiratory tract infection, nasopharyngitis, sinusitis Uncommon: Ce
Eintrag öffnenPyzchiva · 4.8 · Infections and infestations Common: Upper respiratory tract infection, nasopharyngitis, sinusitis Uncommon: Ce
Eintrag öffnenPyzchiva · 4.8 · Infections and infestations Common: Upper respiratory tract infection, nasopharyngitis, sinusitis Uncommon: Ce
Eintrag öffnenPyzchiva · 4.8 · Malignancies In the placebo-controlled period of the psoriasis, psoriatic arthritis, Crohn’s disease and ulcer
Eintrag öffnenPyzchiva · 4.8 · Malignancies In the placebo-controlled period of the psoriasis, psoriatic arthritis, Crohn’s disease and ulcer
Eintrag öffnenPyzchiva · 4.8 · Malignancies In the placebo-controlled period of the psoriasis, psoriatic arthritis, Crohn’s disease and ulcer
Eintrag öffnenPyzchiva · 4.8 · Musculoskeletal and connective Common: Back pain, myalgia, arthralgia tissue disorders Very rare: Lupus-like s
Eintrag öffnenPyzchiva · 4.8 · Nervous system disorders Common: Dizziness, headache Uncommon: Facial palsy
Eintrag öffnenPyzchiva · 4.8 · Paediatric patients weighing at least 40 kg with Crohn’s disease The safety of ustekinumab has been studied in
Eintrag öffnenPyzchiva · 4.8 · Paediatric patients weighing at least 40 kg with Crohn’s disease The safety of ustekinumab has been studied in
Eintrag öffnenPyzchiva · 4.8 · Paediatric population Paediatric patients 6 years and older with plaque psoriasis The safety of ustekinumab ha
Eintrag öffnenPyzchiva · 4.8 · Paediatric population Paediatric patients 6 years and older with plaque psoriasis The safety of ustekinumab ha
Eintrag öffnenPyzchiva · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenPyzchiva · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenPyzchiva · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenPyzchiva · 4.8 · Respiratory, thoracic and Common: Oropharyngeal pain mediastinal disorders Uncommon: Nasal congestion Rare: Al
Eintrag öffnenPyzchiva · 4.8 · Skin and subcutaneous Common: Pruritus tissue disorders Uncommon: Pustular psoriasis, skin exfoliation, acne R
Eintrag öffnenPyzchiva · 4.8 · Skin and subcutaneous tissue Common: Pruritus disorders Uncommon: Pustular psoriasis, skin exfoliation, acne R
Eintrag öffnenPyzchiva · 4.8 · Summary of the safety profile The most common adverse reactions (> 5%) in controlled periods of the adult psor
Eintrag öffnen